Building on positive data from an earlier study, Allrock Bio has dosed the first patients in a small clinical trial testing ROC-101, its oral treatment candidate for pulmonary hypertension (PH). The open-label Phase 2a ROCSTAR study (NCT07175038) is recruiting patients across the U.S., Canada, and Europe — including…
Discussion
Three months after giving birth to my second son in 2023, my life changed in a way I never could have imagined. I am a mom of three boys. Being a “boy mom” has always been the center of my world — busy days, loud laughter, endless energy, and the…
Children with pulmonary hypertension (PH) engage in fewer and shorter bouts of intense physical activity than their peers, according to a new study that measured data from sensors worn on the wrist. Moreover, kids with more severe PH generally had “worse physical testing,” as well as “a steeper decline…
Discussion
Pulmonary hypertension (PH) is a serious and life-threatening disease. There was a time when the hardest part was simply staying alive, getting through each day, and not knowing what came next. But as my health has improved, the challenges have changed. The hardest part for me now isn’t survival.
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
